 | |
- close
- close
Business Wire
Jan 29
Comment
Sparton Corporation (NYSE: SPA) today announced it will host a conference call with investors and analysts on Tuesday, February 16, 2010 at 11:00 a.m. EDT to discuss its fiscal year 2010 second quarter financial results, provide a general business
PR Newswire
Jan 12
Comment
LEXINGTON, Ky., Jan. 12 /PRNewswire/ -- Forget flowers and don't even think about teddy bears this Valentine's Day. Instead show that special someone how much you care with time at the spa. You can indulge your sweetheart with a soothing spa
Business Wire
Jan 6
Comment
Sparton Corporation (NYSE: SPA) today announced that it has been awarded a contract by Norway to manufacture the AN/SSQ-62E DICASS sonobuoy. The award is valued at approximately $1.8 million and will be manufactured at the Company’s De Leon
StreetInsider.com
Jan 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Keryx+Biopharma+%28KERX%29+and+U.S.+FDA+Reach+Agreement+Regarding+a+SPA+for+Zerenex+Phase+3+Design/5218440.html for the full story.
FierceBiotech
Dec 31
Comment
Vion Pharmaceuticals' hopes for a special protocol assessment intended to win an approval for its anti-cancer drug Onrigin have been dashed by the FDA. Regulators rejected the SPA request from Vion, which filed for Chapter 11 bankruptcy protection...
Business Standard
Dec 21
Comment
Nava Bharat (Singapore) Pte Ltd, a subsidiary of Hyderabad-based Nava Bharat Ventures Ltd, has signed a share sale and purchase agreement (SPA) for acquiring a 65 per cent equity stake in Maamba Collieries Ltd (MCL) of Zambia.
Business Times - Malaysia
Dec 15
Comment
MAH Sing Group Bhd announced that its subsidiary Jastamax Sdn Bhd has entered into a sale and purchase agreement (SPA) for the en bloc sale of Apex Tower for RM63.088 million.
The SPA was signed today with a Taiwan national Chen Ho-Yuan, the...
Globe Newswire
Dec 15
Comment
BERKELEY HEIGHTS, N.J., Dec. 15, 2009 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company") announced today that the Company recently held a Type A meeting with the U.S. Food and Drug
Business Wire
Nov 16
Comment
Sparton Corporation (NYSE: SPA) today announced results for the first quarter of fiscal 2010 ended September 30, 2009. The Company reported first quarter net income of $1.4 million, or $0.14 per share, versus a net loss of $3.4 million, or $0.34 loss
Suggest other news sources for this topic
Thank you for your suggestion
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
SPA AT A GLANCE
References
| ||||||
|
|
